Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating the effect of Phyllanthus emblica on COVID-19 patients
IRCT20200404046937N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of phyllanthus emblica in coronavirus disease 2019 (COVID-19), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
phyllanthus emblica
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200404046937N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200404046937N2.